FAIRWOOD HOLD (00052) announced its interim results, with a net profit attributable to equity shareholders of HK$13.215 million, representing a decrease of 14.86% year-on-year.
Great Eagle Holdings Limited (00052) announced its interim results for the six months ended September 30, 2025. The revenue decreased by 2.3% year-on-year to HK$1.5175 billion, and the profit attributable to equity shareholders of the company decreased by 14.86% to HK$13.215 million. Basic earnings per share were HK$0.102, and the interim dividend was HK$0.05 per share.
FAIRWOOD HOLD (00052) announced its interim results for the 6 months ended September 30, 2025. The revenue decreased by 2.3% year-on-year to HK$1.5175 billion, and the profit attributable to equity shareholders of the company decreased by 14.86% to HK$13.215 million. Basic earnings per share were 10.20 HK cents, and the interim dividend was 5.0 HK cents per share.
The announcement stated that the decrease in net profit was mainly due to a decrease in sales, but some of the impact was offset by targeted cost control measures implemented.
Related Articles
HK Stock Market Move | IMMUNEONCO-B(01541) rose over 9% in the afternoon. The phase III clinical trial protocol for IMM0306 has obtained approval from the Center for Drug Evaluation (CDE).
The pharmaceutical industry continues to increase innovation, and we are optimistic about the Chinese medicine market's growth potential in 2026.
HK Stock Market Move | XIAOMI-W(01810) up more than 4% this month's cumulative buyback amount exceeds 1.2 billion Hong Kong dollars. Institutions point out that the company's valuation is attractive.
HK Stock Market Move | IMMUNEONCO-B(01541) rose over 9% in the afternoon. The phase III clinical trial protocol for IMM0306 has obtained approval from the Center for Drug Evaluation (CDE).
The pharmaceutical industry continues to increase innovation, and we are optimistic about the Chinese medicine market's growth potential in 2026.
HK Stock Market Move | XIAOMI-W(01810) up more than 4% this month's cumulative buyback amount exceeds 1.2 billion Hong Kong dollars. Institutions point out that the company's valuation is attractive.
RECOMMEND
Hong Kong Stock Buyback Wave Persists, 247 Listed Companies Repurchase Over HKD 150 Billion This Year
27/11/2025
Mingyu Pharmaceutical Files With HKEX: Ongoing Net Losses Since Inception, No Revenue From Commercial Product Sales
27/11/2025
“Affordability Crisis”! Consumer Confidence Falls To Second Lowest Since The Pandemic, U.S. Retail Slumps
27/11/2025
